174 related articles for article (PubMed ID: 18090927)
1. Different rates of clinical trial enrollment between adolescents and young adults aged 15 to 22 years old and children under 15 years old with cancer at a children's hospital.
Shaw PH; Ritchey AK
J Pediatr Hematol Oncol; 2007 Dec; 29(12):811-4. PubMed ID: 18090927
[TBL] [Abstract][Full Text] [Related]
2. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.
Downs-Canner S; Shaw PH
J Pediatr Hematol Oncol; 2009 Dec; 31(12):927-9. PubMed ID: 19855302
[TBL] [Abstract][Full Text] [Related]
3. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
4. Participation of adolescents with cancer in clinical trials.
Ferrari A; Bleyer A
Cancer Treat Rev; 2007 Nov; 33(7):603-8. PubMed ID: 17250970
[TBL] [Abstract][Full Text] [Related]
5. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials.
Bleyer A; Budd T; Montello M
Cancer; 2006 Oct; 107(7 Suppl):1645-55. PubMed ID: 16906507
[TBL] [Abstract][Full Text] [Related]
6. National cancer clinical trials: children have equal access; adolescents do not.
Bleyer WA; Tejeda H; Murphy SB; Robison LL; Ross JA; Pollock BH; Severson RK; Brawley OW; Smith MA; Ungerleider RS
J Adolesc Health; 1997 Dec; 21(6):366-73. PubMed ID: 9401854
[TBL] [Abstract][Full Text] [Related]
7. No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children's hospital.
Jacob SA; Shaw PH
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28509440
[TBL] [Abstract][Full Text] [Related]
8. Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials.
Ferrari A; Dama E; Pession A; Rondelli R; Pascucci C; Locatelli F; Ferrari S; Mascarin M; Merletti F; Masera G; Aricò M; Pastore G
Eur J Cancer; 2009 Feb; 45(3):328-34. PubMed ID: 19135358
[TBL] [Abstract][Full Text] [Related]
9. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation.
Bleyer A; Montello M; Budd T; Saxman S
Cancer; 2005 May; 103(9):1891-7. PubMed ID: 15795902
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications.
Fern LA; Whelan JS
Semin Oncol; 2010 Apr; 37(2):e1-8. PubMed ID: 20494693
[TBL] [Abstract][Full Text] [Related]
11. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
[TBL] [Abstract][Full Text] [Related]
12. Adolescent and young adult health in a children's hospital: Everybody's business.
Tan J; Cox R; Shannon P; Payne D
J Paediatr Child Health; 2009 Dec; 45(12):715-9. PubMed ID: 19863711
[TBL] [Abstract][Full Text] [Related]
13. Barriers to clinical trial participation by older women with breast cancer.
Kemeny MM; Peterson BL; Kornblith AB; Muss HB; Wheeler J; Levine E; Bartlett N; Fleming G; Cohen HJ
J Clin Oncol; 2003 Jun; 21(12):2268-75. PubMed ID: 12805325
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the recruitment of adolescents and young adults to cancer clinical trials.
Burke ME; Albritton K; Marina N
Cancer; 2007 Dec; 110(11):2385-93. PubMed ID: 17918260
[TBL] [Abstract][Full Text] [Related]
15. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
Yee KW; Pater JL; Pho L; Zee B; Siu LL
J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888
[TBL] [Abstract][Full Text] [Related]
16. Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand.
Dodgshun AJ; De Silva MP; Bradbeer P; Cross S
J Pediatr Hematol Oncol; 2014 Nov; 36(8):630-4. PubMed ID: 24577541
[TBL] [Abstract][Full Text] [Related]
17. Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the state of Georgia.
Howell DL; Ward KC; Austin HD; Young JL; Woods WG
J Clin Oncol; 2007 Oct; 25(29):4610-5. PubMed ID: 17925556
[TBL] [Abstract][Full Text] [Related]
18. No evidence of a trial effect in newly diagnosed pediatric acute lymphoblastic leukemia.
Koschmann C; Thomson B; Hawkins DS
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):214-7. PubMed ID: 20194252
[TBL] [Abstract][Full Text] [Related]
19. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Unger JM; Coltman CA; Crowley JJ; Hutchins LF; Martino S; Livingston RB; Macdonald JS; Blanke CD; Gandara DR; Crawford ED; Albain KS
J Clin Oncol; 2006 Jan; 24(1):141-4. PubMed ID: 16330670
[TBL] [Abstract][Full Text] [Related]
20. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
